VEGF Promoter Polymorphism Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese Population

다국어 초록 (Multilingual Abstract)

Purpose: Evidence on the contribution of genes to the hereditary predisposition to pulmonary arterial hypertension (PAH) is limited.
Materials and Methods: In this study, we hypothesized that single nucleotide variants in vascular endothelial growth factor (VEGF) gene may alter gene function and expression and may be associated with PAH risk. Five putatively functional loci (rs699947C>A and rs833061T>C in the promoter, rs3025040C>T, rs10434G>A and rs3025053G>A in the 3’-UTR) in the VEGF gene were genotyped and analyzed in a retrospective study of 587 patients with PAH and 736 healthy subjects from southern China.
Results: We found that the rs833061T>C polymorphism was significantly associated with PAH risk, while the other single nucleotidepolymorphisms were not. Compared to carriers with TT genotype, those with rs833061C variant genotype (CT/CC) had an increased risk of PAH (odds ratio=1.47, 95% confidence interval=1.18–1.83, p=0.001). Functional assays indicated that CT/CC variant genotype had significantly higher mRNA levels of VEGF in peripheral blood mononuclear cells than TT genotype (p=0.021). Luciferase reporter assay indicated that having a C allele conferred a significantly higher transcription activity than that with a T allele.
Conclusion: Our findings suggest that the functional polymorphism rs833061T>C in VEGF gene promoter modulates VEGF expressionand may be a valuable biomarker for predicting PAH susceptibility.

참고문헌 (Reference)

1 Gnudi L, "Vascular growth factors play critical roles in kidney glomeruli" 129 : 1225-1236, 2015

2 Li Y, "Vascular endothelial growth factor-A (VEGF-A) mediates activin A-induced human trophoblast endothelial-like tube formation" 156 : 4257-4268, 2015

3 Lee CG, "Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung" 10 : 1095-1103, 2004

4 Fearnley GW, "VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration" 4 : 731-742, 2015

5 Smedts HP, "VEGF polymorphisms are associated with endocardial cushion defects: a family-based case-control study" 67 : 23-28, 2010

6 Zhang J, "VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling" 107 : 408-417, 2010

7 Smadja DM, "Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells" 114 : 735-747, 2015

8 Kieran MW, "The VEGF pathway in cancer and disease: responses, resistance, and the path forward" 2 : a006593-, 2012

9 Vannay A, "Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects" 151 : 878-881, 2006

10 Guru SK, "Secalonic acid-D represses HIF1α/VEGF-mediated angiogenesis by regulating the Akt/mTOR/p70S6K signaling cascade" 75 : 2886-2896, 2015

11 Wilcox SR, "Pulmonary hypertension and right ventricular failure in emergency medicine" 66 : 619-628, 2015

12 Sitbon O, "Pathways in pulmonary arterial hypertension:the future is here" 21 : 321-327, 2012

13 Guignabert C, "New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication" 147 : 529-537, 2015

14 de Jesus Perez VA, "Molecular pathogenesis and current pathology of pulmonary hypertension" 21 : 239-257, 2016

15 Uh HW, "Model selection based on logistic regression in a highly correlated candidate gene region" 1 (1): S114-, 2007

16 Nazir N, "Meta-analysis of diabetic nephropathy associated genetic variants in inflammation and angiogenesis involved in different biochemical pathways" 15 : 103-, 2014

17 Baker GJ, "Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGFindependent vascularization, and resistance to antiangiogenic therapy" 16 : 543-561, 2014

18 McLaughlin V, "Managing pulmonary arterial hypertension and optimizing treatment options: prognosis of pulmonary artery hypertension" 111 (111): 10C-15C, 2013

19 Sitbon O, "Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension" 111 : 3105-3111, 2005

20 García-Closas M, "Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk" 3 : e29-, 2007

21 Massena S, "Identification and characterization of VEGF-A-re-sponsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans" 126 : 2016-2026, 2015

22 Soubrier F, "Genetics and genomics of pulmonary arterial hypertension" 62 (62): D13-D21, 2013

23 Jung YW, "Genetic variants of vascular endothelial growth factor are associated with recurrent implantation failure in Korean women" 32 : 190-196, 2016

24 Bull TM, "Gene expression profiling in pulmonary hypertension" 4 : 117-120, 2007

25 박예민, "Functional Class and Targeted Therapy Are Related to the Survival in Patients with Pulmonary Arterial Hypertension" 연세대학교의과대학 55 (55): 1526-1532, 2014

26 Hojo Y, "Expression of vascular endothelial growth factor in patients with acute myocardial infarction" 35 : 968-973, 2000

27 Morin-Brureau M, "Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways" 31 : 10677-10688, 2011

28 Métais C, "Effects of coronary artery disease on expression and microvascular response to VEGF" 275 (275): H1411-H1418, 1998

29 Khayati F, "EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF" 6 : 9766-9780, 2015

30 Humbert M, "Cellular and molecular pathobiology of pulmonary arterial hypertension" 43 (43): 13S-24S, 2004

31 Han X, "Association between VEGF polymorphisms (936c/t, -460t/c and -634g/c) with haplotypes and coronary heart disease susceptibility" 8 : 922-927, 2015

32 Seyfarth HJ, "Angiogenin, bFGF and VEGF: angiogenic markers in breath condensate of patients with pulmonary hypertension" 69 : 207-211, 2015

33 Schmittgen TD, "Analyzing real-time PCR data by the comparative C(T) method" 3 : 1101-1108, 2008

34 Evans I, "An overview of VEGF-mediated signal transduction" 1332 : 91-120, 2015